Archit Organosys Limited

BSE: 524640
Archit Organosys Limited - chemicals and materials in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN L24110GJ1993PLC019941 Incorporated 04 August 1993 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed - BSE: 524640 Public Limited Company chemicals and materials MSME · Medium
Data last updated
Market Cap
₹139 Cr
ARCHITORG · BSE
Share Price
₹69.03
+1.65% today
Revenue
₹113 Cr
FY 2023-24 · -11.4% YoY
EBITDA
₹4.24 Cr
Margin 3.8%
Net Profit
₹0.39 Cr
FY 2023-24 · -96.2% YoY
P/E (TTM)
339.5x
P/B 2.1x
ROE
0.6%
ROCE 3.6%
Debt / Equity
0.46
Interest cover -181.7x

About Archit Organosys Limited

Data last updated:

Archit Organosys Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 04 August 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24110GJ1993PLC019941. The company has 2 GST registrations on record, none of which is active. It is a listed company as per MCA records. Its shares are listed on BSE: 524640.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.52 Cr. It was formerly known as Shri Chlochem Limited. It is led by directors including Archana Kandarp Amin (Whole-Time Director) and Kandarp Krishnakant Amin (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Ahmedabad, Gujarat.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹140.95 Cr, a growth of 12.2% compared to the previous year. For the same year it recorded a net profit of ₹8.03 Cr (net margin 5.7%) and EBITDA of ₹16.41 Cr (EBITDA margin 11.6%). The net worth stands at ₹76.23 Cr (up 10.1% YoY). Total assets are valued at ₹101.59 Cr (up 4.7% YoY).

The company has about 36 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Archit Organosys. As per MCA filings, the company has open charges of ₹93.63 Cr and satisfied charges of ₹7.35 Cr on record. Court records list 66 cases involving the company, including 20 filed by the company and 46 filed against it; 33 cases are pending. The company has 52 deals on record (51 market trades, 1 rights issue); the latest was in March 2024. Its 5 peer companies in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Dr.Acharya Laboratories Private Limited with revenue of ₹131.95 Cr. The company has 5 MSME Form 1 returns on record between 2018 and 2020, listing 177 overdue payments to 18 micro and small suppliers.

Archit Organosys Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0019053). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website architorg.com.

Company details

CIN L24110GJ1993PLC019941
Registration Number 019941
Incorporation Date 04 August 1993
ROC Ahmedabad
Listing Status Listed - Listed on BSE (524640)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-01-0019053
Key People
Archana Kandarp Amin Whole-Time Director Kandarp Krishnakant Amin Whole-Time Director Archit Kandarpbhai Amin Whole-Time Director

Recognitions & Rankings of Archit Organosys

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-01-0019053

Contact details

Archit Organosys Limited's registered office is in Ahmedabad, Gujarat. Its website is architorg.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    architorg.com
  • Social Media
  • Registered Address
    903 9th Floor Venus Benecia Near Pakwan Restaurant, Bodakdev S. G. Highway, Ahmedabad, Gujarat, India – 380054
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Archit Organosys Limited, buy the company report.

Comprehensive company report
Archit Organosys Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Archit Organosys operates one associated brand: Archit Organosys. Each brand links to its own profile.

BrandDescriptionWebsite
Archit Organosys
Manufacturer and suppliers of monochloro acetic acids for laboratory usearchitorg.com

Business activity

The main business activities of Archit Organosys are manufacturing, trade and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, retail trading and other professional, scientific and technical activities. 3 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG2Retail Trading
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Archit Organosys Limited, buy the company report.

Financials of Archit Organosys Limited

FY 2025-26 filings available

Archit Organosys Limited reported revenue of ₹140.95 Cr (up 12.2% YoY) for FY 2025-26.

Financial Highlights

FY 2023-24 · Consolidated
Revenue
₹113 Cr
-11.4% YoY
EBITDA
₹4.24 Cr
-77.5% YoY
Profit After Tax
₹0.39 Cr
-96.2% YoY
Net Worth
₹64.15 Cr
+3.9% YoY
Total Assets
₹90.82 Cr
-2.6% YoY
Total Debt
₹26.44 Cr
-15.8% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2023-24FY 2022-23
Income statement
Revenue113128
Revenue growth-11.4%-
EBITDA4.2418.88
EBITDA margin+3.8%+14.8%
Profit before tax4.3215.35
Net profit0.3910.25
Net profit margin+0.3%+8.0%
EPS (₹)1.605.53
Balance sheet
Total assets90.8293.29
Net worth64.1561.77
Total debt26.4431.41
Cash & bank4.225.38
Net working capital25.3922.82
Cash flow
Cash from operations10.1017.24
Cash from investing(2.17)(10.70)
Cash from financing(9.13)(6.57)
ParticularsMar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022
Revenue30.9924.8126.3931.0046.5522.4228.4630.35
Revenue growth (YoY)-33.4%+10.7%-7.3%+2.1%+77.1%---
Other income4.110.520.540.641.291.840.170.21
EBITDA(0.17)1.102.113.252.913.585.237.17
EBITDA margin-0.5%+4.4%+8.0%+10.5%+6.3%+16.0%+18.4%+23.6%
Depreciation1.021.491.491.191.161.311.171.20
Interest0.640.770.650.520.510.520.320.86
Profit before tax2.28(0.64)0.512.182.533.593.915.32
Tax0.49(0.19)0.140.600.591.360.851.20
Net profit1.79(0.45)0.371.581.942.233.064.12
EPS (₹)0.87(0.22)0.180.770.941.091.492.01
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue14112611312813894.5176.69
Revenue growth+12.2%+11.0%-11.4%-7.3%+45.9%+23.2%-
EBITDA16.4112.974.2418.9016.6411.063.54
EBITDA margin+11.6%+10.3%+3.8%+14.8%+12.1%+11.7%+4.6%
Profit before tax10.997.544.3815.4311.434.68(0.79)
Net profit8.035.080.469.818.535.21(0.88)
Net profit margin+5.7%+4.0%+0.4%+7.7%+6.2%+5.5%-1.2%
EPS (₹)3.912.461.635.574.013.33(0.53)
Balance sheet
Total assets10297.0490.8293.3786.1371.5268.48
Net worth76.2369.2164.1561.8551.8940.5434.11
Total debt25.1427.6026.4431.4133.9730.4233.29
Cash & bank2.250.404.225.385.353.812.95
Net working capital39.7838.4425.3825.7825.8718.2015.59
Cash flow
Cash from operations2.6818.5210.2018.0310.6211.117.74
Cash from investing4.39(20.85)(2.26)(11.50)(11.52)(2.87)(0.82)
Cash from financing(5.77)(1.43)(9.13)(6.57)2.43(7.38)(8.87)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue37.0836.5038.4032.8633.2043.1825.8729.54
Revenue growth (YoY)+11.7%-15.5%+48.4%+11.2%+23.0%---
Other income0.60(0.47)0.901.461.001.060.930.63
Total expenses33.7131.6133.7230.1629.0638.7723.2226.69
EBITDA3.374.894.682.704.144.412.652.85
EBITDA margin+9.1%+13.4%+12.2%+8.2%+12.5%+10.2%+10.2%+9.6%
Depreciation1.501.491.521.521.491.461.491.50
Interest0.440.460.560.670.600.710.470.78
Profit before tax2.032.473.501.973.053.301.621.20
Tax0.580.451.080.431.011.280.610.18

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 04 Nov 2026
ParticularsMar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022
Revenue30.9924.8126.3931.0046.5522.4228.4630.35
Revenue growth (YoY)-33.4%+10.7%-7.3%+2.1%+77.1%---
Other income4.110.520.540.641.291.840.170.21
EBITDA(0.17)1.102.113.252.913.585.237.17
EBITDA margin-0.5%+4.4%+8.0%+10.5%+6.3%+16.0%+18.4%+23.6%
Depreciation1.021.491.491.191.161.311.171.20
Interest0.640.770.650.520.510.520.320.86
Profit before tax2.28(0.64)0.512.182.533.593.915.32
Tax0.49(0.19)0.140.600.591.360.851.20
Net profit1.79(0.45)0.371.581.942.233.064.12
EPS (₹)0.87(0.22)0.180.770.941.091.492.01
ParticularsFY 2023-24FY 2022-23
Revenue113128
Revenue growth-11.4%-
Other income8.323.51
Total expenses109109
Employee cost8.147.37
EBITDA4.2418.88
EBITDA margin+3.8%+14.8%
Depreciation5.664.88
Interest2.582.16
Profit before tax4.3215.35
Tax1.054.01
Net profit0.3910.25
Net profit margin+0.3%+8.0%
EPS (₹)1.605.53
ParticularsFY 2023-24FY 2022-23
Equity & liabilities
Share capital20.5220.52
Reserves & surplus43.6341.25
Shareholders' funds (net worth)64.1561.77
Minority interest0.000.00
Secured loans25.6630.95
Unsecured loans0.780.46
Total debt26.4431.41
Total liabilities90.8293.29
Assets
Gross block83.7469.45
Net block59.6650.45
Capital work in progress0.7016.42
Investments5.873.65
Inventories3.443.38
Sundry debtors22.2337.36
Cash & bank balances4.225.38
Loans & advances11.591.83
Total current assets41.4847.95
Total current liabilities16.0925.13
Net working capital25.3922.82
Total assets90.8293.29
ParticularsFY 2023-24FY 2022-23
Opening cash5.025.05
Net cash from operating activities10.1017.24
Net cash from investing activities(2.17)(10.70)
Net cash from financing activities(9.13)(6.57)
Net change in cash(1.20)(0.03)
Closing cash4.225.38
ParticularsFY 2023-24FY 2022-23
Growth
Sales growth-11.4%-
EBITDA growth-77.5%-
PBT growth-71.9%+9997.0%
Net income growth-96.2%-
Profitability & leverage
Net income margin+2.9%+8.9%
Return on capital employed+3.6%+18.8%
Return on net worth+0.6%+18.4%
Debt / equity0.460.51
Long-term debt / equity0.180.24
Interest cover-181.6915.43
Efficiency & per share
Fixed asset turnover1.481.84
Inventory turnover33.1937.80
Debtors turnover3.803.42
EPS (₹)1.605.53
Dividend per share (₹)0.000.50
Book value per share (₹)31.2630.10
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue37.0836.5038.4032.8633.2043.1825.8729.54
Revenue growth (YoY)+11.7%-15.5%+48.4%+11.2%+23.0%---
Other income0.60(0.47)0.901.461.001.060.930.63
Total expenses33.7131.6133.7230.1629.0638.7723.2226.69
EBITDA3.374.894.682.704.144.412.652.85
EBITDA margin+9.1%+13.4%+12.2%+8.2%+12.5%+10.2%+10.2%+9.6%
Depreciation1.501.491.521.521.491.461.491.50
Interest0.440.460.560.670.600.710.470.78
Profit before tax2.032.473.501.973.053.301.621.20
Tax0.580.451.080.431.011.280.610.18
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue14112611312813894.5176.69
Revenue growth+12.2%+11.0%-11.4%-7.3%+45.9%+23.2%-
Other income2.883.098.383.571.920.542.29
Total expenses12511310910912183.4573.15
Employee cost0.007.106.127.376.516.106.17
EBITDA16.4112.974.2418.9016.6411.063.54
EBITDA margin+11.6%+10.3%+3.8%+14.8%+12.1%+11.7%+4.6%
Depreciation6.015.945.664.884.693.673.47
Interest2.292.582.582.162.443.253.15
Profit before tax10.997.544.3815.4311.434.68(0.79)
Tax2.962.491.054.013.19(0.32)0.01
Net profit8.035.080.469.818.535.21(0.88)
Net profit margin+5.7%+4.0%+0.4%+7.7%+6.2%+5.5%-1.2%
EPS (₹)3.912.461.635.574.013.33(0.53)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital20.5220.5220.5220.5220.5215.0215.02
Reserves & surplus55.7148.6943.6341.3331.3724.1419.09
Shareholders' funds (net worth)76.2369.2164.1561.8551.8940.5434.11
Secured loans24.6626.9525.6630.9532.1229.8733.29
Unsecured loans0.480.650.780.461.850.550.00
Total debt25.1427.6026.4431.4133.9730.4233.29
Total liabilities10297.0490.8293.3786.1371.5268.48
Assets
Gross block84.1082.8683.7469.4562.5861.4861.06
Net block49.8553.9759.6650.4545.0547.6750.42
Capital work in progress0.000.810.7013.7912.752.981.08
Investments6.866.345.873.751.400.300.00
Inventories2.954.303.443.385.943.543.28
Sundry debtors24.5523.0522.2337.3627.3525.0019.72
Cash & bank balances2.250.404.225.385.353.812.95
Loans & advances31.1833.7511.584.754.281.824.33
Total current assets60.9361.5041.4750.8742.9234.1730.28
Total current liabilities21.1523.0616.0925.0917.0515.9714.69
Net working capital39.7838.4425.3825.7825.8718.2015.59
Total assets10297.0490.8293.3786.1371.5268.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.073.825.025.053.812.954.90
Net cash from operating activities2.6818.5210.2018.0310.6211.117.74
Net cash from investing activities4.39(20.85)(2.26)(11.50)(11.52)(2.87)(0.82)
Net cash from financing activities(5.77)(1.43)(9.13)(6.57)2.43(7.38)(8.87)
Net change in cash1.31(3.75)(1.20)(0.03)1.540.86(1.95)
Closing cash2.250.404.225.385.353.812.95
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+12.2%+11.0%-11.4%-7.3%+45.9%+23.2%-
EBITDA growth+26.5%+205.9%-77.6%+13.6%+50.5%+212.4%-
PBT growth+45.8%+72.2%-71.6%+35.0%+144.2%+9998.0%+87.4%
Net income growth+58.1%+1004.4%-95.3%+15.0%+63.7%+692.1%-
Revenue CAGR (3Y)+3.3%-3.1%+6.2%+18.6%+18.0%+5.0%+16.9%
EBITDA CAGR (3Y)-4.6%-8.0%-27.4%+74.8%-+43.0%-1.7%
Profitability & leverage
Net income margin+5.7%+4.0%+2.9%+8.9%+6.0%+5.3%-1.0%
Return on capital employed-+10.8%+3.7%+17.2%+17.6%+11.3%+3.2%
Return on net worth-+7.6%+0.8%+17.3%+17.8%+13.4%-2.6%
Debt / equity-0.410.460.570.700.851.02
Long-term debt / equity-0.100.180.250.280.330.44
Interest cover22.0236.70-181.6915.4120.4243.984,500.00
Efficiency & per share
Fixed asset turnover-1.501.481.942.221.541.33
Inventory turnover-32.4533.1927.4229.0927.7216.82
Debtors turnover-5.553.803.955.274.234.50
EPS (₹)3.912.461.635.574.013.33(0.53)
Dividend per share (₹)1.000.000.000.500.750.500.00
Book value per share (₹)0.0033.7231.2630.1425.2926.0722.71

To see the full year-wise statements and ratios of Archit Organosys Limited, buy the company report.

Board of directors of Archit Organosys Limited

Archit Organosys has 7 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nikul Jagdishchandra Patel
Also directs: Viral Gruh Nirman LLP, Avichal Projects LLP, Devlink Infracon LLP and 5 more
Director05 Aug 20215 Years 3 MonthsCurrent
Archana Kandarp Amin
Also directs: Novel and Nano Xtreme Solutions LLP, Adonis Lifecare Private Limited
Whole-Time Director01 Apr 200917 Years 7 MonthsCurrent
Kandarp Krishnakant Amin
Also directs: Novel and Nano Xtreme Solutions LLP, Archit Life Science Limited, Rajpath Club Limited
Whole-Time Director22 Jan 200026 Years 9 MonthsCurrent
Archit Kandarpbhai Amin
Also directs: Novel and Nano Xtreme Solutions LLP, Archit Life Science Limited, Adonis Lifecare Private Limited
Whole-Time Director12 May 20179 Years 5 MonthsCurrent
Shreeraj Vikram DesaiDirector13 Feb 20206 Years 8 MonthsCurrent
Bhavin Gautamkumar Shah
Also directs: BVS Partners LLP, Makkam Edu Private Limited
Director26 Jun 20233 Years 4 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Archit Organosys Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Archit Organosys Limitedthis company₹140.95 Cr (FY 2026)₹8.03 Cr5.7%12.2%36Ahmedabad, Gujarat, India
Dr.Acharya Laboratories Private Limited₹131.95 Cr (FY 2025)225.0%Mumbai, Maharashtra, India
Dic Ideal Private Limited₹130.59 Cr (FY 2019)22.0%Thane, Maharashtra, India
Vindhyachal Paints & Chemicals Pvt Ltd₹127.16 Cr (FY 2025)49.0%Kolkata, West Bengal, India
Vanu Chemicals Private Limited₹126.45 Cr (FY 2025)4.0%New Delhi, Delhi, India
Shree Sulphurics Private Limited₹126.43 Cr (FY 2025)25.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Archit Organosys Limited, buy the company report.

Auditor

Archit Organosys Limited is audited by CHIRAG R. SHAH & ASSOCAITES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
CHIRAG R. SHAH & ASSOCAITESFY 2022118791W

Shareholding

Shareholding for the quarter ended Mar 2026: promoters hold 65.90%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 34.10%.

Promoters: 65.90%Retail & Others: 34.10%
Mar 2026
QUARTER
65.90% Promoters
34.10% Retail & Others
Promoter holding - history
Now 65.90% · Mar 2026High 65.90% · Dec 2025Low 65.40% · Jun 2025
64%64.8%65.5%66.3%67%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 65.40%Sep 2025: 65.40%Dec 2025: 65.90%Mar 2026: 65.90%65.90%65.40%65.90%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters65.90%65.90%65.40%65.40%
Public34.10%34.10%34.60%34.60%

Charges & borrowings

Open charges
₹93.63 Cr
Satisfied charges
₹7.35 Cr
Breakdown by lending institutions
Others₹93.63 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Mar 200490099808Others₹37.03 CrOpen
13 Jan 200490096878Others₹56.6 CrOpen
24 Feb 2023100690656Others₹3.1 CrSatisfied
26 Mar 201510563657Icici Bank Limited₹25 LakhSatisfied
26 Jun 200490101014Union Bank of India₹1.6 CrSatisfied

To see the full charge records of Archit Organosys Limited, buy the company report.

Total charge records: 9 View all charges

Deals & funding

Archit Organosys Limited has 52 deals on record (51 market trades, 1 rights issue); the latest was in March 2024.

Total deals
52
Market trades
51
Rights issue
1

Deals on record (5 of 52)

WhenDealAmountParties
Nov 2022Market trade₹5.73 CrBuyer: Sera Investments & Finance India Limited , an individual
Seller: Sera Investments & Finance India Limited
Nov 2022Market trade₹2.88 CrBuyer: Sera Investments & Finance India Limited
Seller: an individual
Jul 2022Market trade₹2.25 CrBuyer: Swetsam Stock Holding Private Limited
Seller: an individual
Jul 2022Market trade₹4 CrBuyer: Swetsam Stock Holding Private Limited
Seller: 2 individuals
Jun 2021Market trade₹6.66 CrBuyer: Silkon Trades LLP , 2 individuals
Seller: Silkon Trades LLP , Beeline Merchant Banking Private Limited, 2 individuals

To see the full deal history of Archit Organosys Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Archit Organosys Limited was last rated by Brickwork on 09 Mar 2022.

Rating agencyRated onRating
Brickwork09 Mar 2022

To see the full credit ratings and regulatory alerts of Archit Organosys Limited, buy the company report.

MSME payment delays

Archit Organosys Limited has 5 MSME Form 1 returns on record between 2018 and 2020, listing 177 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 18)

SupplierAmount dueDue sinceReported on
Surya Enterprises
Goldcoin Plastic(India)
Ashapura Logistics Limited
an individual supplier
an individual supplier

To see the full MSME payment records of Archit Organosys Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Archit Organosys has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Archit Life Science LimitedU24290GJ2022PLC135184

To see the full group structure of Archit Organosys Limited, buy the company report.

Employees & EPFO

Archit Organosys Limited has a workforce of 36 employees on its EPFO records as of Apr 06, 2024, across 2 active EPFO establishments.

Employee count
36
Active EPFO establishments
2
Employee growth
-14.29%

GST

Archit Organosys has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of Archit Organosys Limited, buy the company report.

Recent activity

Archit Organosys Limited has 21 board changes on record since 2000: 14 appointments and 7 cessations. The latest: Bhupendra Vishnuprasad Mehta ceased to be Director on 31 Mar 2024.

Charges
A charge with Others of Rs. 37.03 Cr registered on 25 Mar 2004 with Charge ID 90099808 was modified on 10 Jun 2026.
Charges
A charge with Others of Rs. 56.60 Cr registered on 13 Jan 2004 with Charge ID 90096878 was modified on 02 May 2026.
Filing
Archit Organosys Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
AGM
Archit Organosys Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge registered on 24 Feb 2023 via Charge ID 100690656 with Others was fully satisfied on 14 Jul 2025.
Ceased
Bhupendra Vishnuprasad Mehta ceased to be Director.
Appointed
Bhavin Gautamkumar Shah was appointed as Director.
Appointed
Vatsal Shaileshbhai Vora was appointed as Director.
Charges
A charge with Others amounted to Rs. 3.10 Cr with Charge ID 100690656 was registered on 24 Feb 2023.
Appointed
Nikul Jagdishchandra Patel was appointed as Director.
Ceased
Rajendraprasad Jethalal Shah ceased to be Director.
Charges
A charge registered on 22 Nov 2001 via Charge ID 90100780 with Union Bank Of India was fully satisfied on 06 Feb 2021.

31 earlier events are in the company report.

News

Frequently asked questions

Archit Organosys is an active public limited company based in Ahmedabad, Gujarat, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 04 August 1993 (33+ years old) and is registered under CIN L24110GJ1993PLC019941. Listed on BSE: 524640.

Archit Organosys reported revenue of ₹140.95 Cr for FY 2025-26 (up 12.2% YoY) based on standalone financials.

Archit Organosys has 7 current directors:

The latest financial statements of Archit Organosys on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

No. Archit Organosys has 2 GST registrations on record and all of them are cancelled or inactive.

The CIN (Corporate Identification Number) of Archit Organosys is L24110GJ1993PLC019941. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Archit Organosys is a listed company as per MCA records. Its shares are listed on BSE (code: 524640).

Archit Organosys has 66 court cases on record: 20 filed by the company and 46 filed against it. 33 are pending. Most are in the district courts.

Archit Organosys was incorporated on 04 August 1993, making it 33+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Archit Organosys has 52 deals on record (51 market trades, 1 rights issue); the latest was in March 2024.

The peers of Archit Organosys by revenue are Dr.Acharya Laboratories Private Limited, Dic Ideal Private Limited, Vindhyachal Paints & Chemicals Pvt Ltd, Vanu Chemicals Private Limited, Shree Sulphurics Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Bhupendra Vishnuprasad Mehta ceased to be Director on 31 Mar 2024. Bhavin Gautamkumar Shah was appointed as Director on 26 Jun 2023. Vatsal Shaileshbhai Vora was appointed as Director on 26 Jun 2023. Archit Organosys has 21 board changes on record in total.